AKYA Stock Earnings: Akoya Biosciences Meets EPS, Misses Revenue for Q2 2024

    Date:

    Akoya Biosciences (NASDAQ:AKYA) just reported results for the second quarter of 2024.

    • Akoya Biosciences reported earnings per share of -27 cents. This met the analyst estimate for EPS of -27 cents.
    • The company reported revenue of $23.16 million.
    • This was 2.14% worse than the analyst estimate for revenue of $23.67 million.

    InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

    Chart

    SignUp For Breaking Alerts

    New Graphic

    We respect your email privacy

    Share post:

    Popular

    More like this
    Related

    It’s Calculated, Option Price Sensitivity

    Dmitry Pargamanik and Will McBride, the cofounders of Market...

    CPI Brings Relief at the Short End, but Trade Uncertainty Weighs on Duration: Nov. 13, 2024

    Market participants are breathing a sigh of relief in...

    Might the FOMC Spike the Ball Before the End Zone?

    This morning we received the latest report on inflation. ...

    Bond ETFs: You Can Do Both?

    In this episode we explore Bond ETFs. To some listeners, it...